All stock lists
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
Healthcare · Biotechnology
84.95+0.00 (+0.00%)
Insider Score
––Not scored
CRNX Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CRNX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 25.12 M | 10.73 M | 6.16 M | 143.00 K | 1.03 M | 361.00 K |
| Revenue Growth (YoY) | 2336.28 % | 2873.41 % | — | — | 158.40 % | -43.59 % |
| Cost of Revenue | 154.00 K | 200.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 24.96 M | 10.53 M | 6.16 M | 143.00 K | 1.03 M | 361.00 K |
| SG&A Expense | 57.57 M | 50.83 M | 53.70 M | 52.27 M | 49.84 M | 35.53 M |
| R&D Expense | 99.85 M | 100.08 M | 85.05 M | 90.46 M | 80.30 M | 76.24 M |
| Operating Expenses | 157.42 M | 150.91 M | 139.83 M | 142.73 M | 130.14 M | 111.77 M |
| Operating Income | -132.46 M | -140.38 M | -133.67 M | -142.59 M | -129.11 M | -111.41 M |
| Pretax Income | -120.86 M | -127.84 M | -122.64 M | -130.09 M | -115.64 M | -96.77 M |
| Tax Provision | 0.00 | 0.00 | 180.00 K | 0.00 | 0.00 | 0.00 |
| Net Income | -120.86 M | -127.84 M | -122.81 M | -130.09 M | -115.64 M | -96.77 M |
| EPS (Basic) | -1.14 | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 |
| EPS (Diluted) | -1.14 | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 |
| Shares Outstanding | 105.56 M | 104.10 M | 94.06 M | 94.22 M | 93.79 M | 93.10 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.